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ABSTRACT  
Objectives: To evaluate the changing trends in antimicrobial susceptibility rate and detection of ESBL and MBL among Pseudomonas aeruginosa 
isolated from various ocular infections over a 2 year periods with special reference to detection of ESBL and MBL co-existence among P aeruginosa 
recovered from ocular infections. 
Methods: All ocular specimens, culture positive for P aeruginosa (n=110) isolated from clinically suspected patients were submitted to L &T 
Microbiology Research Centre, Chennai, Tamil Nadu, India. Culture, antimicrobial susceptibility testing and ESBL detection was performed by 
Standard methods. MBL production was screened by Carbapenem-EDTA combination disk method. 
Results: Of the 3247 samples subjected to culture from August 2012– July 2014 by standard method 276 were positive for bacterial growth, 
thereby 8.5% of ocular infections mediated by bacterial pathogens. Out of 276 culture positives 110 (39.8%) Pseudomonas aeruginosa isolates 
recovered from ocular infections. The resistance rate for commonly used drugs against ocular infection includes Gentamycin [23.63%], Gatifloxacin 
[20.9%], Moxifloxacin [20%], Tobramycin [20%], ciprofloxacin [19.09%]. Totally 15 (13.63%) out of 110 isolates were identified as ESBL producer 
and 11 (10%) out of 110 isolates were identified as MBL producer by screening test, including 7 isolates have co-produced both ESBL and MBL 
enzymes and 4 isolates were only positive for MBL production. 
Conclusion: Though fluoroquinolones remains a good choice for ocular Pseudomonal infection. Gradual emergence of resistance to 
fluoroquinolones and aminoglycosides also noted from this study. The emergence of ESBL, MBL and pandrug resistance among P aeruginosa from 
ocular infections is an alarm rational finding which necessitates the earlier detection of both ESBL and MBL production as individual or co-existence 
in ocular isolates, which may pave the way for appropriate therapy for sight threatening conditions like endophthalmitis. 
Keywords: Antimicrobial resistance, Pseudomonas aeruginosa, Keratitis, Ocular infections. 
 
INTRODUCTION 
Pseudomonas aeruginosa (P. aeruginosa) is a motile gram-negative 
rod that belongs to the family Pseudomonadaceae. P. aeruginosa, an 
ubiquitous organism frequently isolated from clinical specimens and 
accounts for a significant proportion of nosocomial infections [1]. A 
general problem with nosocomial infections is the tendency of the 
causative pathogen to acquire antibiotic resistance, whilst patient 
was under treatment [2]. P aeruginosa is known for its ability to 
resist killing by a variety of antibiotics. The minimal nutritional 
requirements of Pseudomonas, as evidenced by its ability to grow in 
distilled water and its tolerance to a wide variety of physical 
conditions, contribute to its ecologic success and ultimately in its 
role as an effective opportunistic pathogen [3]. P aeruginosa 
mediated ocular infection is frequently associated with contact lens 
wearer, since the exposure of bacterium to an ocular surface can 
easily occur through contaminated contact lens cases [4]. 
Emergence of P. aeruginosa as a major infective cause of corneal 
ulceration termed keratitis and, accounting for 8-21% of bacterial 
keratitis in South India [5]. Multidrug resistant (MDR) P aeruginosa 
keratitis is an increasing clinical problem wherein the treatment for 
patient becomes complicated, leading to blindness. The infection is 
an avoidable blindness recognized as a public health threat.  
The mechanism of antibiotic resistance may be intrinsic (the 
microorganism is by definition resistant against a certain antibiotic) 
or acquired. Production of beta-lactamases is considered of major 
importance among resistant mechanisms, because these enzymes 
are frequently transferable and inactivate beta lactam antibiotics for 
a broad range. Out of this large enzymatic family, carbapenemases 
(class B) metallobetalactamases (MBLs) that contain zinc in their 
active site and class A KPC hydrolyze in vitro all or almost all beta-
lactams, including carbapenems. The Class A extended spectrum 
beta-lactamases (ESBLs) hydrolyze penicillins, monobactams and 
cephalosporins whereas they are inhibited by the available beta-
lactamase inhibitors [6]. 
Since, phenotypic method is an inexpensive, simple technique with 
fair reproducible result with easy interpretation method and can be 
used in any basic laboratories. The rational of this study is to detect 
and evaluate the ability of P aeruginosa recovered from ocular 
isolate(s) for the production of ESBL and MBL enzyme neither single 
nor coproduction of both enzymes using phenotypic methods. In 
literatures, scanty reports on ESBL and MBL producers among 
ocular isolates of P aeruginosa have been reported. In this context, 
the current study is a need for accurate and up to date information 
on the frequency and mode of resistance, resistance trends and 
comprehensive comparison of various antimicrobial agents tested 
against Pseudomonas aeruginosa in ocular infections. 
Thus the information on the emergence of resistance with different 
antibiotics can be of practical use in guiding empiric therapeutic 
choices. In this study, we report the results of antibiotic susceptibility 
and multiple antibiotic resistance index of P aeruginosa isolates 
obtained from ocular specimens submitted to L & T Microbiology 
Research centre, Sankara Nethralaya, Chennai, Tamil Nadu, and India. 
The proposed study method can be used routinely to test 
antimicrobial sensitivity for accurate identification of resistant 
mechanism to guide the clinician for with appropriate drug regimen 
decision in the chemotherapy of P aeruginosa infections. 
MATERIALS AND METHODS 
A prospective analysis was done with 110 Pseudomonas aeruginosa 
isolated from patients with clinical diagnosis of bacterial ocular 
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diseases, namely conjunctivitis, canaliculitis, keratitis, dacryocystitis, 
endophthalmitis, and panophthalmitis during the 2-year periods 
(July 2012–December 2014) from a total of 3247 specimens 
received for microbial culture at L & T Microbiology Research 
Centre, Kamalnayan Bajaj Research Centre, Sankara Nethralaya, a 
tertiary eye care center at Chennai, India. Study protocol was 
approved by the institutional ethics sub-committee (IRB). After the 
ocular examinations, using standard microbiological techniques, 
specimens for culture and smear were obtained (7, 8).  
(ii) Identification of Pseudomonas aeruginosa isolates 
The different ocular specimens submitted to L & T Microbiology 
Research Centre were cultured on blood agar, MacConkey agar and 
Brain Heart Infusion Broth (BHIB) and they were incubated at 37 °C 
for 24 hours and on Mueller Hinton agar plates to assess pigment 
production. The culture plates were processed using standard 
microbiological procedures, Characterization and identification of P. 
aeruginosa was carried out using a combination of colonial 
morphology, Gram stain characteristics, motility tests, pigmentation, 
oxidation-fermentation tests, catalase and oxidizer activity tests and 
pyocyanin production [9]. Detailed distribution of Pseudomonas 
aeruginosa among the ocular specimens was shown in table 1.  
Phenotypic detection method 
We used Standardard method of drug susceptibility testing using 
Muller-Hinton agar and bacterial isolates to be tested (in 0.5 
McFarland's standard concentration), quality control strains 
Escherichia coli ATCC 35218 (positive control-ESBL) Klebsiella 
pneumoniae 700603 (MBL-Positive control) and Escherichia coli 
ATCC 25922 (negative control). One isolate was studied from each 
patient. The drug susceptibility pattern screened for Pseudomonas 
aeruginosa strains to Penicillins: ampicillin (10µg), amoxycillin 
(20µg), piperacillin (100µg); cephalosporins: cephalexin (30 µg), 
cefuroxime (30µg), cefazolin (30µg), cefotaxime (30µg), ceftriaxone 
(30µg), ceftazidime (30µg), cefoperazone (75 µg), cefpodoxime 10 
µg), cefdinir (5 µg), cefepime (30 µg); Carbepenems: imipenem 
(10µg), meropenem (10 µg); monobactums: aztreonem (30 µg); 
combinations: ampicillin+sulbactum (10/10 µg), 
amoxycillin+clavulinic acid (20/10 µg), piperacillin+tazobactum 
(100/10 µg); Aminoglycosides: gentamicin (10 µg), tobramycin (10 
µg), amikacin (30 µg); quinolones: ciprofloxacin (5µg), ofloxacin 
(5µg), levofloxacin (5µg), gatifloxacin (5µg); tetracyclines: 
doxycycline (30µg); macrolides: azithromycin (15µg) and 
miscellaneous: chloramphenicol (30 µg) respectively was 
investigated by the Kirby-Bauer disc diffusion method according to 
CLSI guidelines [10].  
Mueller-Hinton broth was used as the growth medium. The final 
bacterial inoculum concentration was adjusted to 1.5x108 colony-
forming units/ml (cfu/ml) followed by plates were inoculated with 
swabs submerged in the final inoculum concentration and swabbed 
over the entire surface of the media. The relevant antibiotic discs 
were placed over and incubated aerobically at 35-370
ESBL detection 
C for 18-24 
hours. All antibiotic discs were obtained from Hi-media. 
Pseudomonas aeruginosa ATCC 27853 was used as control for 
identification and susceptibility tests.  
ESBL test was performed by placing disks of ceftazidime (30 µg), 
cefotaxime(30 µg), ceftazidime-clavulanic acid(30/10 µg), and 
cefotaxime-clavulanic acid (30/10 µg), on Muller-Hinton agar (MHA) 
plates at a distance of 30 mm (center to center) from each other. 
ESBL production was inferred if the zones produced by the disks 
with clavulanate (an ESBL inhibitor) were ≥5 mm larger than those 
without inhibitor [11,12].  
MBL detection 
Phenotypic detection of MBL production (EDTA-IMP) was carried 
out for imipenem-resistant strains by dissolving 186.1 grams of 
disodium EDTA. 2H2
RESULTS 
O in 1000 ml of distilled water, 0.5 M EDTA 
solution was prepared and adjusted to pH 8 by adding sodium 
hydroxide. Then, 750 μg /disc was prepared by adding 5 microlitres 
of 0.5M EDTA solution per disc and was dried in the incubator. 
EDTA-imipenem (IMP) disk plus imipenem disk were placed in a 
MHA plate containing lawn culture of P. aeruginosa. After 18 h of 
incubation at 37 °C an organism was considered MBL positive if the 
inhibition zone diameter increased by ≥7 mm towards the IMP plus 
EDTA or Meropenem(MER) plus EDTA in comparison to IMP or MER 
disk alone [11, 12]. 
The present investigation was carried out to isolate and identify 
Pseudomonas aeruginosa from ocular specimens. All the 
Pseudomonas aeruginosa isolates were identified and confirmed 
based on various characteristics: colony morphology, bluish green 
pigmentation, non lactose fermenting colonies in macconckey agar, 
presence of motility, positive reaction for oxidase, catalase, 
simmon's citrate medium, nitrate reduction and mannitol sugar test 
and negative reaction for urease, indole, Methyl Red, Vogues Prosker 
test, sucrose, lactose and maltose sugar tests.  
Of the 3247 samples subjected to culture from August 2012– July 
2014 by standard method 276 were positive for bacterial growth, 
thereby suggesting 8.5% of ocular infections mediated by bacterial 
pathogens. Out of 276 culture positives, 110 (39.8%) isolates were 
found to be Pseudomonas aeruginosa. Among, 110 P aeruginosa 
isolates, 101 (91.8%) specimens were only positive for P aeruginosa 
growth and 8 (7.27%) isolates were identified with groups of 
bacterial strains other than P aeruginosa and 1 isolate (0.90%) was 
found to presence of fungal growth. The polymicrobial distribution 
of these 8 isolates were predominantly isolated from 7 (5.45%) 
corneal scraping composed of Staphylococcus epidermidis (3), 
Klebsiella pneumonia (2) and Aspergillus flavus(1) and 2 (1.81%) 
isolates were identified from eviscerated material with 
Staphylococcus epidermidis (2). 
Of the 110 clinical isolates, the maximum number was isolated from 
34 (37.4%) corneal scraping followed by 19 (20.9%) conjunctival 
swab (significant number of colonies found in any one culture media 
and BHIB were considered to be positive growth), 11(12.1%) 
vitreous aspirate and eviscerated material, 10(11%) corneal button, 
7 (7.7%) Donor corneal Rim (DCR), 6 (6.6%) contact lens and each 1 
(0.91%) from scleral scraping, corneal pus, infective suture, iris 
tissue, bandage from contact lens, conjuctival scraping and 
intraocular lens.  
Out of 110 P aeruginosa tested, drug susceptibility rate was higher 
for beta lactam group of drugs such as 109 (99.09%) Aztreonam, 
104 (94.5%) Cefepime, 100 (90.90%) for both Meropenem and 
cefdinir, 99(90%) Imipenem drug and the least susceptibility rate 
for 70 (63.63%) piperacillin followed by 76 (69.09%) amoxycillin 
and 80 (72.72%) cephalexin. Aminoglycosides suscebtibility was 96 
(87.27%) amikacin followed by 83 (74.54%) tobramycin and 76 
(69.09%) gentamycin. Quinolones/Fluoroquinolone susceptibility 
was 86 (78.18%) for both ciprofloxacin and gatifloxacin followed by 
83(75.45%) moxifloxacin and 82(74.54%) for both norfloxacin and 
ofloxacin (Graph: 1) 
Results for ESBL & MBL test 
In ESBL confirmatory-cephalosporin/clavulanate combination disc 
test, Totally 15 (13.63%) out of 110 isolates displayed positive 
results against cefotaxime with clavulanic acid compared to 
cefotaxime alone and ceftazidime with clavulanic acid compared to 
ceftazidime alone. Among, 15 isolates 5 (5.5%) belonged to corneal 
button and 4 (4.4%) from corneal scraping isolates, 3 (3.3%) donor 
corneal rim and three each from Eviscerated material, vitreous 
aspirate, conjuctival swab respectively. MBL screening test using 
carbapenem-EDTA combination test showed 11 (10%) out of 110 
positive results against Imipenem with EDTA compared to 
Imipenem alone and/or meropenem with EDTA as compared to 
meropenem alone. Out of 11 MBL positive isolates, corneal button 3 
(2.72%), corneal scraping 4 (4.4%), donor corneal rim 2 (1.81%) 
and eviscerated material2 (1.81%). The co-existence of both ESBL 
and MBL were identified in 7 (6.36%) out of 110 isolates consist of 
corneal scraping 3(2.72%), corneal button 2 (1.81%) and each 1 
(0.91%) from donor corneal rim and eviscerated material (table 1, 
Graph 2). 
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Fig. 1: ESBL confirmatory test-Double disk diffusion method. 
The inhibition zone around the CAC disk is apparently larger 
than around the CA disk, indicating ESBL production. But no 
comparable result is obtained with CEC disk and CE disk. 
Abbreviations: CA, Ceftazidime (30 µg); CAC, 
Ceftazidime+clavulanic acid (30/10 µg); CE, Cefotaxime (30 
µg);CEC, Cefotaxime+Clavulanic acid (30/10 µg) 
 
 
Fig. 2: Carbapenenem-EDTA Combination disk method for MBL 
detection. The inhibition zone around the IPM+EDTA and 
MRP+EDTA disk is apparently larger than around the IPM and 
MRP disk respectively, indicating MBL production. 
Abbreviations: IPM, Imipenem (10 µg); IPM+EDTA, Imipenem 
(10 µg)+5 µl 0.5M EDTA; MRP, Meropenem (10 µg); MRP+EDTA, 
Meropenem (10 µg)+5 µl 0.5M EDTA
 
Graph 1: Antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolated from ocular infections 
 
 
Graph 2: Specimen wise distribution of P aeruginosa and its betalactamases-ESBL and MBL mechanism detected by phenotypic method 
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Table 1: Shows distribution of ESBL and MBL results among ocular specimens identified by phenotypic methods 
S. 
No. 






 ESBL negative MBL 
positive  
Total No of 
MBL 
1 Donor Corneal Rim 7 (6.36%) 3 1 1 2 
2 Aqueous chamber Tap 4(3.63%) 0 0 0 0 
3 Corneal scraping 34 (30.9%) 4 3 1 4 
4 Conjuctival swab Donor 
Eye 
1 (0.9%) 0 0 0 0 
5 Contact lens 6 (5.45%) 0 0 0 0 
6 Corneal button 10 (9.09%) 5 2 1 3 
7 Eviscerated material 11(10.0%) 1 1 1 2 
8 Vitreous aspirate 11 (10.0%) 1 0 0 0 
9 Conjuctival swab 19 (17.27%) 1 0 0 0 
10 Scleral scraping 1 (0.9%) 0 0 0 0 
11 Canalicular pus 1 (0.9%) 0 0 0 0 
12 Infective suture 1 (0.9%) 0 0 0 0 
13 Iris tissue 1 (0.9%) 0 0 0 0 
14 Bandage lens 1 (0.9%) 0 0 0 0 
15 Conjuctival scraping 1 (0.9%) 0 0 0 0 
16 Intra ocular lens 1 (0.9%) 0 0 0 0 
 Total 110 
(100%) 








Keratitis and other ocular infections mediated by Pseudomonas 
aeruginosa is a significant cause of ocular morbidity and permanent 
blindness. Henceforth, it should be considered as an emergency and 
requires careful and urgent attention to initiate appropriate therapy 
[13]. The present study was initiated, due to increased rate of MDR 
P. aeruginosa encountered in ocular specimens. Currently, ESBL and 
MBL production were not screened routinely in microbiology labs 
due to cost and other factors. Despite, genetic analysis were 
standard for MBL production, due to equipments required for PCR 
analysis which is not affordable to all basic microbiological labs. 
Hence, we carried out the carbapenem-EDTA combination disk 
method for identification of MBLs among P aeruginosa recovered 
from ocular isolates. 
In the current study P. aeruginosa was predominantly isolated from 
corneal ulcer 34 (30.9%). Trauma or infection was found to be the 
major risk factor for the development of P aeruginosa keratitis 
followed by pre-operative conjuctival swab 19 (17.27%). Contact 
lens (6 (5.45%)) wearer does not emerge as an important risk 
factor, though it is noted as a predominant cause for Pseudomonas 
keratitis in developed countries [4]. This difference could be 
attributed to the difference in type of contact lens being used among 
developed and developing countries as well as this study included 
mostly urban population hence their care of Contact lens usage and 
environmental factor plays major role [14]. 
The emergence of antibiotic resistant bacteria increases the patients 
stay at hospital, thus leading to an increased economic burden on 
them. In the present study, the antibiogram of the 110 isolates of P. 
aeruginosa showed resistance against piperacillin [36.36%], 
amoxycillin [29.09%], ampicillin and cephalexin [27.27%], 
cephozoline [26.36%] though amoxycillin, ampicillin were not used 
in ocular treatment, we screened those drugs in order to evaluate 
susceptibility pattern of P aeruginosa from ocular infection with 
other infections. Among the drugs commonly used for treating 
ocular infections, increased resistance was noted against 
Gentamycin [23.63%], Gatifloxacin [20.9%], Moxifloxacin [20%], 
Tobramycin [20%], ciprofloxacin [19.09%]. Our findings were 
similar to the observations by Ibukun et al., who reported a higher 
susceptibility [15]. Our findings differed from those of Diwivedi et 
al., Arya M et al. who reported a higher resistant rate among isolates 
obtained from post operative wound infections [16, 17]. Result of 
this study, shows that P aeruginosa from ocular isolates were more 
susceptible to newer fluoroquinolones, amikacin, Ciprofloxacin, 
Gatifloxacin and Moxifloxacin. However resistance rates is gradually 
emerging among P aeruginosa against gentamicin and moxifloxacin. 
These findings may show less similar to other researchers (Haleem 
et al., 2011, Ferguson et al., (2007) compared with our results [18-
19], which is due to the isolate of our study included only ocular 
specimens, whereas most of the study includes wide group of 
specimens such as blood, urine, pus and etc., Studies with ocular 
isolates by (MJ Bharathi et al., 2002 and 2011) results were 
concordance with our findings [8,20]. 
Our study showed that among 110 Pseudomonas aeruginosa isolates, 
15 [13.63%] were ESBL producers, which was nearly similar to 
20.27 % and 22.22% ESBL producing isolates of P. aeruginosa 
reported by Aggarwal et al., Peshattiwar PD et al. [12,21]. The ESBL 
mediated resistance of P. aeruginosa to the third generation 
cephalosporins was non concordance with report of Uma et al. 
[77.3%], was much higher than that reported in the present study 
[22]. The interesting finding in our study is the identification of 7 
ocular isolates for coproduction of both ESBL and MBL enzymes 
which is not observed by Peshattiwar PD et al. and Renata Picao et 
al. [12, 23].  
We observed that only 9.09 % strains were resistant to carbapenem. 
In the present study, imipenem and meropenem showed good 
antipsuedomonal activity. A similar observation was made by 
Jaykumar S and Peshattiwar PD et al. 12,24], while a higher degree 
of carbapenem resistance was noted by Varaiya et al. [25%] [25]. 
This difference could be attributable to the study environment and 
nature of ocular specimens. 
The most concerning development in recent years has been the 
emergence of carbapenemases among MDR P. aeruginosa. It is 
alarming to the scientific community that resistance to imipenem 
9(8.18%) and meropenem 10(9.09%) resistance is observed among 
ocular P aeruginosa. Out of 110 P aeruginosa isolated, 11 [10%] 
isolates were found to be metallo β lactamases producers. The 
prevalence of MBLs in the present study was consistent with 
findings of Ibukun et al., Navaneeth et al., Peshattiwar PD et al., and 
others [12,15,26]. In the present study, 5 isolates [45.45 % out of 11] 
MBLs were resistant to all the antibiotics tested except aztreonam 
and one strain from eviscerated material showed resistance to all 
drugs including aztreonam. The presence of MBLs in the pandrug 
resistant isolates was already observed by Jaykumar S [24]. But 
emerging scenario of P aeruginosa with pandrug resistant strain(s) 
among ocular infections is an alert for scientific community which 
may leads to blindness. 
In conclusion, the emergence of ESBL and MBL among P aeruginosa 
strains is noted in ocular setup. Earlier detection of co-existence of 
ESBL and MBL production by MDR P aeruginosa may pave the way 
for appropriate therapy. Further, our study underlines the unique 
problem of ESBL and MBL mediated resistance, which has created a 
therapeutic challenge for the clinicians and microbiologists. To 
overcome the problem of emergence and the spread of multidrug 
resistant P. aeruginosa, a combined interaction and cooperation 
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between the microbiologists, clinicians and the infection control 
team is needed. So, efforts should be aimed at detecting such 
resistant bacteria along with their resistance mechanisms, 
controlling infections caused by them, and finally, providing better 
alternative therapies against these recalcitrant organisms. 
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